Stryker earns FDA clearance for new bone and soft tissue removal platform

Stryker (NYSE: SYK) earned an FDA 510(k) clearance for its latest ultrasonic bone and soft tissue removal platform, the Sonopet 3.

The system adds enhancements to the company’s Sonopet offerings, such as pulse control, which gives providers added ability to regulate hard and soft tissue resection, as well as Stryker’s Reimagined Integrated Surgical Experience (RISE) technology for a connected surgical workflow.

Stryker said it developed the advanced platform with input from hundreds of surgeons who informed key performance improvements, workflow efficiency and clinical priorities.

Sign up for Blog Updates